Pharma Video Marketing in India: 7 Trends Shaping 2026
The Evolving State of Pharma Video in India
India's pharmaceutical industry spent an estimated ₹3,800 crore on promotional activities in 2025. Video's share of that spend has grown from under 10% in 2020 to over 28% in 2025 — and is projected to exceed 40% by 2027.
What's driving this shift, and what should pharma marketers be doing about it?
---
Trend 1: AI-Assisted MOA Animation
Mechanism of Action animations used to require 8–12 weeks and ₹15–25 lakh for a single 2-minute video. AI-assisted animation workflows are reducing both timelines and costs dramatically.
The result: companies can now produce vertical-specific MOA variants (e.g., "MOA for cardiologists" vs. "MOA for GPs") at a fraction of previous costs.
What this means: Small and mid-size Indian pharma companies can now access MOA-quality content that was previously reserved for MNC budgets.
---
Trend 2: HCP Micro-Targeting on LinkedIn and YouTube
Healthcare professional targeting on LinkedIn has matured significantly. Specialty-level targeting (e.g., "cardiologists in Mumbai with 5+ years' experience") is now achievable with budgets as low as ₹50,000/month.
YouTube's HCP content consumption has grown 3x since 2022. Pharma companies using unskippable pre-roll on medical conference content are achieving CPMs of ₹180–320.
---
Trend 3: Patient Education at Scale via WhatsApp
India has 560 million WhatsApp users. For chronic disease management brands (diabetes, hypertension, COPD), WhatsApp video is outperforming email, SMS, and even in-app notifications for patient engagement.
A 60-second "medication reminder" or "lifestyle tip" video shared via branded WhatsApp Business accounts is achieving open rates of 65–80%.
---
Trend 4: CME-Linked Content for KOL Engagement
Continuing Medical Education (CME) video content is growing as a vehicle for HCP engagement. Brands that produce genuinely educational CME content — with no promotional messaging — build long-term KOL relationships that translate into prescribing behavior.
NABH and MCI-accredited CME video modules are increasingly valued by specialists who need verifiable CPD hours.
---
Trend 5: Regional Language Video for Tier-2/3 Markets
Hindi, Gujarati, Marathi, Tamil, and Telugu versions of HCP education videos are opening up massive tier-2 and tier-3 markets that national brands have historically underserved.
A 3-minute product education video in Gujarati for community pharmacists in Saurashtra can drive prescription behavior in a market segment that no MNC field force reaches efficiently.
---
Trend 6: KOL Interview Series for Credibility
Short-form KOL (Key Opinion Leader) interview series — 5–7 minute "expert perspective" videos on therapeutic areas — are outperforming branded promotional content for organic reach and HCP trust.
Best practice: produce 4–6 episodes per series, distribute on YouTube and LinkedIn, and cross-promote with the featured KOL's own network.
---
Trend 7: QR-Coded Leave-Behind Videos
Medical reps increasingly leave QR codes linking to product videos — MOA animations, patient education content, clinical data summaries — rather than printed collateral. QR code video engagement rates in pharma are running at 22–35%, far above printed leave-behind response rates.
---
Positioning Your Brand for 2026
BanyanTree Communications has been producing pharma video content for 30 years. We've adapted through every shift in the medium — from VHS training tapes to AI-assisted 3D animation.
[Talk to our pharma team today](/contact-us) about your 2026 video content strategy.